Literature DB >> 7827236

Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women.

M Gaard1, S Tretli, P Urdal.   

Abstract

In this prospective study, the relationship between blood lipids and breast cancer risk was examined. Between 1977 and 1983, 31,209 Norwegian women, 20 to 54 years of age, attended a health screening carried out by the Norwegian National Health Screening Services. The screening consisted of a questionnaire, anthropometric measurements, and nonfasting blood drawn for analysis of total serum cholesterol (TC), triglyceride (TG), and high density lipoprotein (HDL) cholesterol. Low density lipoprotein (LDL) cholesterol was calculated by the Friedewald's formula. During the seven to 13 years of follow-up, 302 breast cancer cases were identified by linkage to the Norwegian Cancer Registry. After adjustment for some of the known risk factors of breast cancer, the relative risk of women in the highest quartile of TC compared with women in the lowest quartile was 0.87 (95 percent confidence interval [CI] = 0.61-1.23). The corresponding relative risks and CIs were 0.82 (CI = 0.58-1.16) for TG, 1.02 (CI = 0.73-1.42) for HDL, and 0.93 (CI = 0.67-1.29) for LDL. No association between breast cancer risk and blood lipids was found in the total population, nor when the data were divided into those diagnosed before or after the age of 50 as a dividing line between pre- and postmenopausal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827236     DOI: 10.1007/bf01831377

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  38 in total

1.  Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure.

Authors:  S A Törnberg; L E Holm; J M Carstensen
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

2.  Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women.

Authors:  L J Vatten; O P Foss
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 4.  Ischemic heart disease and lipids in blood and diet.

Authors:  R A Stallones
Journal:  Annu Rev Nutr       Date:  1983       Impact factor: 11.848

5.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

6.  Changes in lipoprotein composition during the menstrual cycle.

Authors:  H J Kim; R K Kalkhoff
Journal:  Metabolism       Date:  1979-06       Impact factor: 8.694

7.  Distribution of high-density lipoprotein cholesterol according to age, sex, and ethnic origin: cardiovascular disease study in Finnmark 1977.

Authors:  D S Thelle; O H Førde; E Arnesen
Journal:  J Epidemiol Community Health       Date:  1982-12       Impact factor: 3.710

8.  Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer.

Authors:  K Kumar; P Sachdanandam; R Arivazhagan
Journal:  Biochem Int       Date:  1991-02

9.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

Review 10.  The search for the causes of breast and colon cancer.

Authors:  W Willett
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

View more
  23 in total

Review 1.  The metabolic syndrome: A high-risk state for cancer?

Authors:  Stephanie Cowey; Robert W Hardy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

2.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

3.  Cholesterol, lipoproteins, and breast cancer risk in African American women.

Authors:  Adana A Llanos; Kepher H Makambi; Cynthia A Tucker; Sherrie Flynt Wallington; Peter G Shields; Lucile L Adams-Campbell
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

4.  Total cholesterol and cancer risk in a large prospective study in Korea.

Authors:  Cari M Kitahara; Amy Berrington de González; Neal D Freedman; Rachel Huxley; Yejin Mok; Sun Ha Jee; Jonathan M Samet
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

5.  The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women.

Authors:  Parisa Tehranifar; Angeline Protacio; Karen M Schmitt; Elise Desperito; Sabine Oskar; Alan J Potter; Natalie J Engmann; Mary Beth Terry
Journal:  Cancer Causes Control       Date:  2015-07-14       Impact factor: 2.506

Review 6.  Metabolic syndrome and cancer.

Authors:  Pooja Pothiwala; Sushil K Jain; Subhashini Yaturu
Journal:  Metab Syndr Relat Disord       Date:  2009-08       Impact factor: 1.894

7.  HDL-cholesterol and incidence of breast cancer in the ARIC cohort study.

Authors:  Anna M Kucharska-Newton; Wayne D Rosamond; Pamela J Mink; Anthony J Alberg; Eyal Shahar; Aaron R Folsom
Journal:  Ann Epidemiol       Date:  2008-09       Impact factor: 3.797

8.  Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.

Authors:  Mathilde His; Laurent Zelek; Mélanie Deschasaux; Camille Pouchieu; Emmanuelle Kesse-Guyot; Serge Hercberg; Pilar Galan; Paule Latino-Martel; Jacques Blacher; Mathilde Touvier
Journal:  Eur J Epidemiol       Date:  2014-02-13       Impact factor: 8.082

9.  Metabolic syndrome and outcomes following early-stage breast cancer.

Authors:  Gregory S Calip; Kathleen E Malone; Julie R Gralow; Andy Stergachis; Rebecca A Hubbard; Denise M Boudreau
Journal:  Breast Cancer Res Treat       Date:  2014-10-10       Impact factor: 4.872

10.  The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.

Authors:  Selvakumar Elangovan; Rajneesh Pathania; Sabarish Ramachandran; Sudha Ananth; Ravi N Padia; Ling Lan; Nagendra Singh; Pamela M Martin; Lesleyann Hawthorn; Puttur D Prasad; Vadivel Ganapathy; Muthusamy Thangaraju
Journal:  Cancer Res       Date:  2013-12-26       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.